Business Description
Chandra Bhagat Pharma Ltd
ISIN : INE07QQ01016
Share Class Description:
BOM:542934: Ordinary SharesCompare
Compare
Traded in other countries / regions
542934.India IPO Date
2020-02-14Description
Chandra Bhagat Pharma Ltd is engaged in the business of marketing pharmaceutical critical care and health care products. The company provides a pharmaceutical formulation in therapeutic categories for formulations such as Anti-cancer (Oncology), Antibiotics, Anesthesia, Hormones, Orthopedic, Cardiac, Cardiovascular, Anti-fungal, Antiviral, Pediatrics, Cardiology, Nephrology, Neurology, and others. It is also engaged in promoting and marketing Active Pharmaceuticals Ingredients (APIs) in India.
Financial Strength
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.13 | |||||
| Equity-to-Asset | 0.31 | |||||
| Debt-to-Equity | 0.77 | |||||
| Debt-to-EBITDA | 5.43 | |||||
| Piotroski F-Score | 7/9 | |||||
| Altman Z-Score | 3.01 | |||||
| Beneish M-Score | -0.8 | |||||
| WACC vs ROIC | ||||||
Growth Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 46.3 | |||||
| 3-Year EBITDA Growth Rate | 1.4 | |||||
| 3-Year EPS without NRI Growth Rate | 77.9 | |||||
| 3-Year FCF Growth Rate | -22.3 | |||||
| 3-Year Book Growth Rate | 3.9 |
Momentum Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 73.78 | |||||
| 9-Day RSI | 55.71 | |||||
| 14-Day RSI | 49.86 | |||||
| 6-1 Month Momentum % | -19.77 | |||||
| 12-1 Month Momentum % | -47.73 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.4 | |||||
| Quick Ratio | 1.4 | |||||
| Cash Ratio | 0.05 | |||||
| Days Inventory | 22.95 | |||||
| Days Sales Outstanding | 83.74 | |||||
| Days Payable | 27.31 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Shareholder Yield % | -2.69 |
Profitability Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 12.39 | |||||
| Operating Margin % | -1.59 | |||||
| Net Margin % | 0.95 | |||||
| FCF Margin % | -0.58 | |||||
| ROE % | 5.46 | |||||
| ROA % | 1.85 | |||||
| ROIC % | -3.01 | |||||
| ROC (Joel Greenblatt) % | 13.59 | |||||
| ROCE % | 10.78 | |||||
| Years of Profitability over Past 10-Year | 8 |
GF Value Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 32.89 | |||||
| PE Ratio without NRI | 43.31 | |||||
| Price-to-Owner-Earnings | 11.97 | |||||
| PS Ratio | 0.31 | |||||
| PB Ratio | 1.75 | |||||
| Price-to-Tangible-Book | 1.7 | |||||
| Price-to-Operating-Cash-Flow | 173.56 | |||||
| EV-to-EBIT | 20.53 | |||||
| EV-to-EBITDA | 16.83 | |||||
| EV-to-Revenue | 0.42 | |||||
| EV-to-FCF | -71.68 | |||||
| Price-to-Projected-FCF | 0.97 | |||||
| Price-to-Graham-Number | 1.78 | |||||
| Price-to-Net-Current-Asset-Value | 2 | |||||
| Earnings Yield (Greenblatt) % | 4.88 | |||||
| FCF Yield % | -1.9 | |||||
| Forward Rate of Return (Yacktman) % | 4.12 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Chandra Bhagat Pharma Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ₹) | 1,670.285 | ||
| EPS (TTM) (₹) | 2.1 | ||
| Beta | 0.36 | ||
| Volatility % | 37.51 | ||
| 14-Day RSI | 49.86 | ||
| 14-Day ATR (₹) | 1.089856 | ||
| 20-Day SMA (₹) | 66.9045 | ||
| 12-1 Month Momentum % | -47.73 | ||
| 52-Week Range (₹) | 63 - 148 | ||
| Shares Outstanding (Mil) | 7.55 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 7 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Chandra Bhagat Pharma Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Chandra Bhagat Pharma Ltd Stock Events
| Event | Date | Price(₹) | ||
|---|---|---|---|---|
| No Event Data | ||||
Chandra Bhagat Pharma Ltd Frequently Asked Questions
What is Chandra Bhagat Pharma Ltd(BOM:542934)'s stock price today?
The current price of BOM:542934 is ₹67.06. The 52 week high of BOM:542934 is ₹148.00 and 52 week low is ₹63.00.
When is next earnings date of Chandra Bhagat Pharma Ltd(BOM:542934)?
The next earnings date of Chandra Bhagat Pharma Ltd(BOM:542934) is .
Does Chandra Bhagat Pharma Ltd(BOM:542934) pay dividends? If so, how much?
Chandra Bhagat Pharma Ltd(BOM:542934) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers